367 related articles for article (PubMed ID: 30913193)
1. ACOG Committee Opinion No. 774 Summary: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
Obstet Gynecol; 2019 Apr; 133(4):842-843. PubMed ID: 30913193
[TBL] [Abstract][Full Text] [Related]
2. ACOG Committee Opinion No. 774: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
Obstet Gynecol; 2019 Apr; 133(4):e279-e284. PubMed ID: 30913199
[TBL] [Abstract][Full Text] [Related]
3. The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage.
Naumann RW; Hughes BN; Brown J; Drury LK; Herzog TJ
Am J Obstet Gynecol; 2021 Oct; 225(4):397.e1-397.e6. PubMed ID: 33798477
[TBL] [Abstract][Full Text] [Related]
4. Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada.
Hanley GE; Kwon JS; McAlpine JN; Huntsman DG; Finlayson SJ; Miller D
Am J Obstet Gynecol; 2020 Aug; 223(2):221.e1-221.e11. PubMed ID: 32067967
[TBL] [Abstract][Full Text] [Related]
5. Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada.
Hanley GE; Kwon JS; Finlayson SJ; Huntsman DG; Miller D; McAlpine JN
Am J Obstet Gynecol; 2018 Aug; 219(2):172.e1-172.e8. PubMed ID: 29852159
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of opportunistic salpingectomy vs tubal ligation at the time of cesarean delivery.
Venkatesh KK; Clark LH; Stamilio DM
Am J Obstet Gynecol; 2019 Jan; 220(1):106.e1-106.e10. PubMed ID: 30170036
[TBL] [Abstract][Full Text] [Related]
7. Risks and benefits of opportunistic salpingectomy during vaginal hysterectomy: a decision analysis.
Cadish LA; Shepherd JP; Barber EL; Ridgeway B
Am J Obstet Gynecol; 2017 Nov; 217(5):603.e1-603.e6. PubMed ID: 28619689
[TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer prevention by opportunistic salpingectomy is a new de facto standard in Germany.
Runnebaum IB; Kather A; Vorwergk J; Cruz JJ; Mothes AR; Beteta CR; Boer J; Keller M; Pölcher M; Mustea A; Sehouli J
J Cancer Res Clin Oncol; 2023 Aug; 149(10):6953-6966. PubMed ID: 36847838
[TBL] [Abstract][Full Text] [Related]
9. No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.
Salvador S; Scott S; Francis JA; Agrawal A; Giede C
J Obstet Gynaecol Can; 2017 Jun; 39(6):480-493. PubMed ID: 28527613
[TBL] [Abstract][Full Text] [Related]
10. Hysterectomy with opportunistic salpingectomy versus hysterectomy alone.
van Lieshout LAM; Steenbeek MP; De Hullu JA; Vos MC; Houterman S; Wilkinson J; Piek JM
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD012858. PubMed ID: 31456223
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention.
Dilley SE; Havrilesky LJ; Bakkum-Gamez J; Cohn DE; Michael Straughn J; Caughey AB; Rodriguez MI
Gynecol Oncol; 2017 Aug; 146(2):373-379. PubMed ID: 28577884
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic salpingectomy for the prevention of ovarian cancer: Who should we target?
Kotsopoulos J; Narod SA
Int J Cancer; 2020 Sep; 147(5):1245-1251. PubMed ID: 32037528
[TBL] [Abstract][Full Text] [Related]
13. Opportunistic Salpingectomy at the Time of Urogynecologic Surgery: Why, in Whom, and How?
Catanzarite T; Eskander RN
Female Pelvic Med Reconstr Surg; 2020 Jun; 26(6):401-406. PubMed ID: 31135579
[TBL] [Abstract][Full Text] [Related]
14. Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention.
McAlpine JN; Hanley GE; Woo MM; Tone AA; Rozenberg N; Swenerton KD; Gilks CB; Finlayson SJ; Huntsman DG; Miller DM;
Am J Obstet Gynecol; 2014 May; 210(5):471.e1-11. PubMed ID: 24412119
[TBL] [Abstract][Full Text] [Related]
15. The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States.
Mandelbaum RS; Adams CL; Yoshihara K; Nusbaum DJ; Matsuzaki S; Matsushima K; Klar M; Paulson RJ; Roman LD; Wright JD; Matsuo K
Am J Obstet Gynecol; 2020 Nov; 223(5):721.e1-721.e18. PubMed ID: 32360846
[TBL] [Abstract][Full Text] [Related]
16. [Current surgical practice of prophylactic and opportunistic salpingectomy in France].
Chene G; de Rochambeau B; Le Bail-Carval K; Beaufils E; Chabert P; Mellier G; Lamblin G
Gynecol Obstet Fertil; 2016; 44(7-8):377-84. PubMed ID: 27363615
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of salpingectomy at hysterectomy to reduce the risk of epithelial ovarian cancer: a systematic review.
Darelius A; Lycke M; Kindblom JM; Kristjansdottir B; Sundfeldt K; Strandell A
BJOG; 2017 May; 124(6):880-889. PubMed ID: 28190289
[TBL] [Abstract][Full Text] [Related]
18. The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States.
Hanley GE; McAlpine JN; Pearce CL; Miller D
Am J Obstet Gynecol; 2017 Mar; 216(3):270.e1-270.e9. PubMed ID: 27810554
[TBL] [Abstract][Full Text] [Related]
19. Menopausal symptoms and surgical complications after opportunistic bilateral salpingectomy, a register-based cohort study.
Collins E; Strandell A; Granåsen G; Idahl A
Am J Obstet Gynecol; 2019 Jan; 220(1):85.e1-85.e10. PubMed ID: 30321526
[TBL] [Abstract][Full Text] [Related]
20. Current Updates on Salpingectomy for the Prevention of Ovarian Cancer and Its Practice Patterns Worldwide.
Dhakal S; Zheng YX; Yi XF
Chin Med Sci J; 2017 Sep; 32(3):185-192. PubMed ID: 28956746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
